|
1 Indications And Usage Airduo ® Respiclick ® Is Indicated For The Treatment Of Asthma In Patients Aged 12 Years And Older. Airduo Respiclick Should Be Used For Patients Not Adequately Controlled On A Long Term Asthma Control Medication Such As An Inhaled Corticosteroid Or Whose Disease Warrants Initiation Of Treatment With Both An Inhaled Corticosteroid And Long Acting Beta 2 Adrenergic Agonist (Laba). Limitations Of Use : Airduo Respiclick Is Not Indicated For The Relief Of Acute Bronchospasm. Airduo Respiclick Is A Combination Of Fluticasone Propionate, A Corticosteroid, And Salmeterol, A Long-Acting Beta 2 -Adrenergic Agonist (Laba), Indicated For Treatment Of Asthma In Patients Aged 12 Years And Older. Airduo Respiclick Should Be Used For Patients Not Adequately Controlled On A Long Term Asthma Control Medication Such As An Inhaled Corticosteroid Or Whose Disease Warrants Initiation Of Treatment With Both An Inhaled Corticosteroid And Long Acting Beta 2 -Adrenergic Agonist (Laba). ( 1 ) Limitations Of Use: Not Indicated For The Relief Of Acute Bronchospasm. ( 1 )
|